Mike Hennessy Jr.

Mike Hennessy Jr. is the President and CEO of MJH Life Sciences.

Articles

Voice of Regulators

Next year's "FDA Voices" series will cover core topics FDA staff are prioritizing.

Optimizing Quality

The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.

What Does Cost Mean?

While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.

The Stick and Carrot of Quality Management

How can we fix the quality manufacturing issues that come with product shortages?

How Can We Come Up Short So Often?

Systemic inefficiencies in the pharmaceutical industry undermine problem-solving efforts.

Is AI a Panacea for Pharma’s Productivity Gap?

AI could provide solutions to critical manufacturing inefficiencies.

Back to INTERPHEX

Spring has returned, and with it comes INTERPHEX.

Major League Moves

Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.

Locating Logic in Pharma Manufacturing

Reducing US dependency on overseas pharma manufacturing may prove critical in navigating supply chain disruptions.

A License to Innovate

Busy is good for business.